Pfizer

Pfizer is one of the world's largest biopharmaceutical companies, headquartered in New York City, with full-year 2024 revenues of roughly $63.6 billion and 2025 revenue guidance of approximately $62 billion. Its portfolio spans vaccines (Comirnaty), antivirals (Paxlovid), and a growing roster of biologics and specialty injectables (e.g., the Vyndaqel family), increasingly delivered as sterile parenteral products in vials, prefilled syringes, and autoinjectors. Pfizer operates a global GMP manufacturing network including major sterile injectables sites (e.g., Kalamazoo MI, Melbourne AU) and is actively trialing AI and robotics to support aseptic/fill-finish operations and contamination control under the EU GMP Annex 1 regime. For AGD purposes the relevant contact-rich opportunity sits in aseptic fill-finish interventions and drug-device combination assembly, where fragile glass, sterility constraints, and variable component geometry make feel-based manipulation valuable.